Halozyme Therapeutics Inc.


HALO

Price

40.68


Change

-0.05


High

40.99


Low

40.44


Avg Volume

992,759


PE Ratio

19.37


52 Week High

45


52 Week Low

29.85



Profile

Halozyme Therapeutics is a U.S. biotechnology company that develops novel oncology therapies designed to target the tumor microenvironment and licenses a novel drug delivery technology through corporate partnerships. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California.


Top Streaming News


Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.

Data provided by IEX Cloud

About

Copyright © 2020 Finaza.IO. All Rights Reserved.